Armistice Capital »

Genelux Corporation shares owned by Armistice Capital

Quarter-by-quarter ownership of Genelux Corporation (GNLX) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Genelux Corporation

Tip: Access up to 7 years of quarterly data

All positions including Genelux Corporation held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Genelux Corporation by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.8M 900k 1.95

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Immunovant (IMVT)
Agios Pharmaceuticals (AGIO)
Argenx Se Sponsored Adr (ARGX)
Novo-nordisk A S Adr (NVO)
Sanofi Sponsored Adr (SNY)
Alkermes SHS (ALKS)
Medtronic SHS (MDT)
Aurinia Pharmaceuticals (AUPH)

View all positions for Armistice Capital

Top funds holding Genelux Corporation

Woodward Diversified Capital
Vanguard Group
Armistice Capital
Highbridge Capital Management
BlackRock
Millennium Management
Bank of America Corporation
Geode Capital Management
Goldman Sachs Group
Northern Trust
Provident Wealth Management
Affinity Asset Advisors
Charles Schwab Investment Management
Morgan Stanley
Y-Intercept

View all funds holding Genelux Corporation